Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avalon Biomed develops and manufactures advanced bioactive bioceramic dental materials for endodontics. Their products, such as NeoMTA Plus, are widely used by endodontists and general dentists to improve outcomes in root canal therapy and related procedures. The company has several new bioceramic products in the pipeline focused on both endodontic and pediatric indications. Clinical results emphasize improved tooth preservation with fewer reparative procedures due to superior material properties.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avalon Biomed.